19
votes
The million-dollar drug: How a Canadian medical breakthrough that was thirty years in the making became the world’s most expensive drug — and then quickly disappeared
Link information
This data is scraped automatically and may be incorrect.
- Title
- The million-dollar drug
- Published
- Nov 17 2018
- Word count
- 1242 words
I can see their reasoning here. After all the treatment only requires 1 dose of the drug and you're set for life. It can be thought of as taking the drug for 20 years, divide 1 million by 20 and you get 50k a year. Which is not really that crazy.
Also you need to consider that LPLD is a very rare disease, so the company who sells Glybera will have very few customers. It's really hard to stay profitable or at least break even without pricing the drug really high.
In a perfect world the government should be the one who is funding these kinds of drugs.
I wonder if this drug is patented? If not then it could be picked up by different companies, and through competition it's price will hopefully drop to an affordable value.
Very interesting article!
As I read it, it was government (i.e. public) money that funded the discovery and initial development of the drug. The researchers worked at public universities. But now private industry gets to decide if it's profitable enough to produce or not...
Frustratingly, the article doesn't say what the manufacturing costs are which are the other half the equation for determining economic possiblity and/or profitability...